NCT05677685View on ClinicalTrials.gov

VISUPRIME® Eye Drops

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

June 22, 2023

Primary Completion Date

January 23, 2024

Study Completion Date

January 23, 2024

Conditions
Macular Degeneration, Age RelatedMyopic Choroidal NeovascularisationProliferative Diabetic RetinopathyDiabetic Macular EdemaMacular Edema of Right Retina (Diagnosis)
Interventions
DEVICE

VISUPRIME

twice daily

DEVICE

Placebo

twice daily

Trial Locations (6)

28100

Azienda Ospedaliero Universitaria Maggiore della Carità, Novara

34148

Azienda Sanitaria Universitaria Giuliano Isontina, Trieste

70124

Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Bari

80131

Azienda Ospedaliera Universitaria Federico II, Napoli

06156

Ospedale Santa Maria della Misericordia, Perugia

00168

Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome

All Listed Sponsors
collaborator

CROlife

UNKNOWN

lead

VISUfarma SpA

INDUSTRY